Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype.
about
PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressorPhase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias.The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.Emerging cell cycle inhibitors for acute myeloid leukemia.Targeting the ATR-CHK1 Axis in Cancer TherapyThe cell cycle checkpoint inhibitors in the treatment of leukemias.Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia.Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia.
P2860
Q35951377-5621369A-6B52-4F86-BDFA-87AC04E704EDQ36680199-AFDFD56F-75B2-4F88-B146-79F6004789B0Q36927012-B7342EFA-556D-4FB7-8B0E-926EF17936CCQ38238954-6982E387-1710-433A-84D5-0D0B78CE6251Q38694866-9238E78B-B00E-4606-9539-75BEA6FEF9EDQ38785380-D7A3D34F-AECF-4DAA-BA28-F081F3338646Q38817102-04D0C370-370E-4DBB-9FDF-235489644B6EQ38868502-33FB9DB9-DB1A-4896-851E-70481CC22F81Q39142229-58DF5BDA-4B33-4C1B-A680-445140CCFCE9Q47730914-736AD995-83D2-4E30-A27F-CBEA3F906C1C
P2860
Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluation of checkpoint kinas ...... ukemia with complex karyotype.
@ast
Evaluation of checkpoint kinas ...... ukemia with complex karyotype.
@en
type
label
Evaluation of checkpoint kinas ...... ukemia with complex karyotype.
@ast
Evaluation of checkpoint kinas ...... ukemia with complex karyotype.
@en
prefLabel
Evaluation of checkpoint kinas ...... ukemia with complex karyotype.
@ast
Evaluation of checkpoint kinas ...... ukemia with complex karyotype.
@en
P2093
P2860
P356
P1476
Evaluation of checkpoint kinas ...... ukemia with complex karyotype.
@en
P2093
Cécile Demur
Denis Jullien
Fanny Grimal
Stéphane Manenti
P2860
P304
P356
10.4161/CBT.19074
P577
2012-03-01T00:00:00Z